A new homogeneous enzyme immunoassay using recombinant enzyme fragments.

Homogeneous enzyme immunoassays have played a major role in the development of simple and easy to use diagnostic tests for clinical laboratory instrumentation. A novel homogeneous enzyme immunoassay system, CEDIA, has been developed using enzyme fragments prepared by recombinant DNA technology. Two separate genes are engineered to express two separate polypeptide fragments: enzyme-donor (ED) and enzyme-acceptor (EA). These fragments can spontaneously recombine to form active beta-galactosidase enzyme. Ligands can be attached to the ED peptide in such a way that the degree of recombination is controlled by the binding of anti-ligand antibodies to the enzyme donor-ligand conjugate. CEDIA methodology is based on the competition between ligand in the sample and ED-ligand conjugate for limiting the amount of antibody binding sites. The advantages of the CEDIA immunoassay system over conventional homogeneous EIA's include a linear dose response curve and lower limits of detection of analytes in human body fluids. The demonstrated sensitivity achievable with CEDIA technology suggests further applications on a wide range of analytes including vitamins, hormones, drugs and cancer markers. A new variant of CEDIA technology leading to a single liquid reagent immunoassay useful for on-site testing has also been developed.

[1]  E. F. Ullman,et al.  "Homogeneous" enzyme immunoassay. A new immunochemical technique. , 1972, Biochemical and biophysical research communications.

[2]  A. Fowler,et al.  Amino acid sequence of beta-galactosidase. XI. Peptide ordering procedures and the complete sequence. , 1978, The Journal of biological chemistry.

[3]  B. van Weemen,et al.  Immunoassay using antigen—enzyme conjugates , 1971, FEBS letters.

[4]  J. F. Kolhouse,et al.  Absorption, plasma transport, and cellular retention of cobalamin analogues in the rabbit. Evidence for the existence of multiple mechanisms that prevent the absorption and tissue dissemination of naturally occurring cobalamin analogues. , 1977, The Journal of clinical investigation.

[5]  B. Gould,et al.  Use of enzymes in immunoassay techniques. A review , 1984 .

[6]  J. Burd,et al.  Homogeneous substrate-labeled fluorescent immunoassay for IgG in human serum. , 1981, Journal of immunological methods.

[7]  R. Boguslaski,et al.  Flavin adenine dinucleotide as a label in homogeneous colorimetric immunoassays. , 1981, Analytical chemistry.

[8]  H. Lenhoff,et al.  Antibody-induced conformational restriction as basis for new separation-free enzyme immunoassay. , 1983, Biochemical and biophysical research communications.

[9]  D. Henderson,et al.  CEDIA, a new homogeneous immunoassay system. , 1986, Clinical chemistry.

[10]  S. Berson,et al.  Assay of Plasma Insulin in Human Subjects by Immunological Methods , 1959, Nature.